Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 480.00
Bid: 480.00
Ask: 482.50
Change: 0.00 (0.00%)
Spread: 2.50 (0.521%)
Open: 480.50
High: 484.00
Low: 480.00
Prev. Close: 480.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Oct 2021 07:00

RNS Number : 5678O
Treatt PLC
11 October 2021
 

11 October 2021

TREATT PLC

("Treatt" or "the Group")

Trading update for the year ended 30 September 2021

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today publishes a trading update for the year ended 30 September 2021 ("FY21").

Highlights

64% revenue growth across healthier living categories, with tea a stand-out performer.Stronger margins driven by a number of fast growing, higher margin categories and a more value-add, solution-based citrus portfolio.Transition of people and production to the new UK facility underway, which will triple UK production capacity once completed (anticipated in FY23).FY21 profit before tax and exceptional items expected to be in line with previously upgraded Board expectations.A positive outlook for the new financial year: the order book is up materially year-on-year and the Board remains committed to ongoing strategic investments to support multiple longer term market opportunities.

 

FY21 performance

Following on from the strong performance in H1, momentum continued into H2, reflecting our increasing focus on innovative, added-value products. Following upgraded guidance in January 2021 and May 2021, the Board expects to report profit before tax and exceptional items for FY21 in line with its revised expectations.

Revenue for the year is anticipated to be c.£124m, an increase of c.14% (c.18% in constant currency) compared with the prior year. Revenue growth was driven by categories focused on healthier living; our tea, health & wellness (including sugar reduction) and fruit & vegetables categories grew by a combined 64% in FY21.

Within our healthier living categories, tea performed exceptionally well, growing by 113% to represent 11% of Group revenue (FY20: 6%). This growth was driven by the return of on-trade in many parts of the world, together with material new product launches by customers which had been delayed due to the pandemic. Health & wellness (including sugar reduction) had another strong year, growing by 29% as the drive to reduce the calorific content in beverages shows no sign of abating and represented 8% of Group revenue (FY20: 7%). Passion fruit, watermelon, cucumber and mango natural extracts led the way in the fruit & vegetables category which has been growing consistently for many years, with strong growth in FY21 of 60%, and represented 10% of Group revenue (FY20: 7%).

Reported revenue from our citrus category, which contributed 44% of Group revenue (FY20: 50%), remained broadly similar to the prior year, however, gross profit margin improved as we continued to strategically shift away from lower margin activities towards higher value, solution-based products.

The Group's traditional range of herbs, spices & florals, representing 9% of Group revenue (FY20: 11%), saw revenues remain broadly unchanged in the year. Whilst 'natural' now represents approximately 80% of the Group's portfolio, revenue from our portfolio of sustainable synthetic aroma products into the flavour and fragrance market grew by 9%.

The pre-pandemic market trends for 'better-for-you' and natural products continues in both the alcoholic and non-alcoholic beverage sectors and the Group won numerous new customers in the year, whilst expanding with existing ones. In particular, the Group continues to grow its presence in the burgeoning alcoholic seltzer market as new brands and new flavour combinations compete for market share. With our two routes to market, being direct to brand owners and indirectly through flavour houses, the Group has a strong position in multiple leading seltzer brands as well as in a number of challenger brands, which has had a positive impact across a number of our product categories.

Whilst the well documented global supply chain issues have inevitably been felt by our logistics teams, to date this has not materially impacted the Group. Treatt does not have large numbers of container movements on a daily basis, instead transporting concentrated product, and the Group has continued to hold prudent levels of inventory in order to mitigate supply chain risks for our customers.

In a major milestone for the Group, we have begun transitioning to our new state-of-the-art facility in the UK. Many colleagues are now based at the new site and we are in the process of installing and commissioning plant and machinery which will transform our UK manufacturing capabilities to an advanced digital system. We expect our technical, and most of our manufacturing capabilities to be fully up and running at the new facility by mid-2022, with the final transfer and upgrade of our most complex manufacturing equipment due to be completed by mid-2023. We have exchanged contracts on the disposal of our old site for an aggregate consideration, net of costs, of c.£5.5m, with completions due in 2022 and a leaseback on one of the units until 2023. Once fully up and running, subject to product mix, the new facility will be capable of delivering up to three times the output of our old UK site.

Cash and dividends

The Group ended the year with net debt of approximately £6m despite significant capital investment in the year of £9.5m in our new UK facility, whilst retaining total bank facilities of £26m. The Board confirms its intention to propose a final dividend in line with its dividend policy.

Outlook

Following a year of significant growth, momentum continues with order books materially up year-on-year. Consequently the Group enters the new financial year with a positive outlook. In order to support future growth, we will continue to invest in the products, people and production capacity to capitalise on the multiple longer term market opportunities we see across the business.

In the current financial year we expect to see our healthier living categories continuing to perform strongly, and our new coffee category to begin monetising some material opportunities. Our citrus category is expected to continue its transition up the value chain and our sustainable synthetic aroma business is set for further growth. Geographically we are excited about the growth opportunities which our China business is working on, whilst the US is set to continue as our largest market.

Daemmon Reeve, CEO of Treatt, commented:

"It has been a great year for Treatt, with some fantastic achievements across the Group, despite the backdrop of Covid-19. My thanks go to all of our colleagues for their tremendous endeavours and commitment.

"In an evolving consumer market, we continue to make great strides in products that facilitate healthier living and we have increasingly strong capabilities allowing us to innovate and partner more closely with our customers.

"We have much to look forward to as a Group and continue to invest in our people and infrastructure to ensure we sharpen our focus on value-add solutions for our customers and can take advantage of the multiple opportunities we see for further success in the future."

Treatt's results for the year ended 30 September 2021 are expected to be announced on 30 November 2021.

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Joint Brokers

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Andrew Clark

Will Bell

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Simon Hockridge

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRIILTIIL
Date   Source Headline
29th Sep 20153:02 pmRNSTotal Voting Rights
2nd Sep 20152:19 pmRNSNotification of Transactions of Directors
27th Aug 201511:06 amRNSTotal Voting Rights
10th Aug 201511:44 amRNSDirector/PDMR Shareholding
21st Jul 20151:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20153:23 pmRNSDirector/PDMR Shareholding
10th Jun 20154:57 pmRNSDirector/PDMR Shareholding
4th Jun 20157:00 amRNSBlock Listing Six Monthly Return
1st Jun 201511:48 amRNSDirector/PDMR Shareholding
27th May 201512:07 pmRNSTotal Voting Rights
21st May 20155:11 pmRNSDirector/PDMR Shareholding
19th May 20157:00 amRNSHalf Yearly Report
14th Apr 20153:52 pmRNSDirector/PDMR Shareholding
8th Apr 20153:16 pmRNSDirector/PDMR Shareholding
30th Mar 20153:10 pmRNSDirector/PDMR Shareholding
30th Mar 20157:04 amRNSTrading Statement
23rd Mar 20153:15 pmRNSDirector/PDMR Shareholding
18th Mar 20154:59 pmRNSDirector/PDMR Shareholding
11th Feb 20154:19 pmRNSUpdate on Earthoil Earn-out Dispute
30th Jan 20154:09 pmRNSResult of AGM
14th Jan 20153:42 pmRNSDirector/PDMR Shareholding
8th Jan 201510:18 amRNSDirector/PDMR Shareholding
5th Jan 20153:26 pmRNSReplacement Director/PDMR Shareholding
5th Jan 201511:30 amRNSDirector/PDMR Shareholding
31st Dec 20147:00 amRNSAnnual Information Update
31st Dec 20147:00 amRNSTotal Voting Rights
16th Dec 20145:02 pmRNSDirector/PDMR Shareholding
12th Dec 20143:56 pmRNSAnnual Financial Report
9th Dec 20147:00 amRNSFinal Results
2nd Dec 20147:00 amRNSBlock Listing Application
28th Oct 20143:00 pmRNSVoting Rights and Capital
23rd Oct 20142:38 pmRNSDirector/PDMR Shareholding
7th Oct 20144:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20141:50 pmRNSDirector/PDMR Shareholding
1st Oct 20147:00 amRNSTrading Statement
30th Sep 20144:02 pmRNSTotal Voting Rights
29th Sep 20144:25 pmRNSDirector/PDMR Shareholding
1st Sep 20149:22 amRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNSTotal Voting Rights
1st Aug 20142:25 pmRNSDirector/PDMR Shareholding
29th Jul 201410:03 amRNSDirector/PDMR Shareholding
29th Jul 20147:00 amRNSInterim Management Statement
1st Jul 20143:44 pmRNSDirector/PDMR Shareholding
1st Jul 20148:32 amRNSDirector/PDMR Shareholding
30th Jun 20143:17 pmRNSHolding(s) in Company
23rd May 20144:39 pmRNSHolding(s) in Company
20th May 20147:00 amRNSHalf Year Results
19th May 20149:47 amRNSVoting Rights and Capital
16th May 201412:07 pmRNSResult of EGM
16th Apr 20141:41 pmRNSNotice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.